MEDIA CENTER
Microbicides 2008
Striving Towards HIV Prevention
24–27 February 2008

Presentations by Population Council Staff and Colleagues
Names of Council researchers and colleagues appear in boldface type.
    

Poster Presentations
Display from Monday, 25 February (8:00–10:00 am) through end of conference	"Decision making and the influences of others in the informed consent process: A qualitative investigation in the Phase 3 study of Carraguard®" (Abstract no. 566, Track C) (PDF) Authors: Sharon Abbott, Barbara Friedland, Lauren Katzen, Alana de Kock, Sphiwe Madiba, and Sheila Cishe
	"The prevalence of STIs in HIV-positive and HIV-negative women screened during the Phase 3 Carraguard® clinical trial in South Africa" Author: Khatija Ahmed
	"Impact of provision of hormonal contraception on pregnancy incidence in women enrolled in the Phase 3 Carraguard® clinical trial at three sites in South Africa" (Abstract no. 508, Track B) (PDF) Authors: N. Cele, Thesla Palanee, N. Myeni, N. Mnyandu, Z. Langa, E. Shange, Marlena Gehret, Pekka Lähteenmäki, Stephanie Skoler, Lydia Altini, Smruti Patel, Khatija Ahmed, Nazira Cassim, and Gita Ramjee
	"Impact of acceptability on adherence in the Carraguard® Phase 3 trial" (Abstract no. 570, Track C) (PDF) Authors: Barbara Friedland, Sarah Littlefield, Stephanie Skoler, Alana de Kock, Thesla Palanee, Marlena Gehret, Lauren Katzen, Neetha Morar, Vuyelwa Mehlomakulu, and Manuela M. Williams
	"Evaluation of a video to enhance the informed consent process in the Phase 3 Carraguard® trial" (Abstract no. 569, Track C) (PDF) Authors: Barbara Friedland, Stephanie Skoler, Alana de Kock, Lauren Katzen, Louis Apicella, Manuela M. Williams, Vuyelwa Mehlomakulu, and Vuyelwa Mtimkulu
	"Qualitative evaluation of the informed consent process in the Phase 3 Carraguard® efficacy trial: Study staff experiences and recommendations for future trials" (PDF) Authors: Lauren Katzen, Barbara Friedland, Sharon Abbott, Alana de Kock, Sphiwe Madiba, and Sheila Cishe
	"Male partner involvement in the Carraguard® Phase 3 trial: Data from a qualitative study of the informed consent process" (PDF) Authors: Sphiwe Madiba, Barbara Friedland, Sharon Abbott, Lauren Katzen, Alana de Kock, and Sheila Cishe
	"Strategies to increase male involvement and product adherence in the Phase 3 Carraguard® trial in Durban, South Africa" (PDF) Authors: N.L. Makhanya, Thesla Palanee, and Gita Ramjee
	"Acceptability of the vaginal microbicide Carraguard® among couples in Chiang Rai, Thailand" (PDF) Authors: Sarah Martin, Kelly Blanchard, Chomnad Manopaiboon, Supaporn Chaikummao, Kate Schaffer, Barbara Friedland, and Peter H. Kilmarx
	"Assessing the reporting of adherence and sexual activity in a simulated microbicide trial: Preliminary results from an interview mode experiment in the Phase 3 Carraguard® sites, South Africa" (Abstract no. 468, Track B) (PDF) Authors: Barbara Mensch, Paul Hewett, Johanna Rankin, Sarah Littlefield, Sharon Abbott, Khatija Ahmed, Nazira Cassim, Smruti Patel, Vuyelwa Mehlomakulu, Gita Ramjee, Thesla Palanee, Stephanie Skoler, Marlena Gehret, and Sumen Govender
	"Value of a defined HIV testing algorithm in resolution of discordant and indeterminate results in the Phase 3 Carraguard® trial, South Africa" (PDF) Authors: Thesla Palanee, Marlena Gehret, Pekka Lähteenmäki, Stephanie Skoler, S. Eghan, Sumentheran N. Govender, Lydia Altini, Khatija Ahmed, and Gita Ramjee
	"Ensuring care through adequate referrals and community partnerships for women participating in HIV prevention trials: Experience from the Phase 3 Carraguard® trial in Isipingo, KwaZulu Natal, Durban, South Africa" (PDF) Authors: Thesla Palanee and Gita Ramjee
	"Acceptability of Carraguard® vaginal gel among HIV-infected women—Results from a randomized, controlled, crossover trial, Thailand" (PDF) Authors: Sara J. Whitehead, C.M. McLean, Supaporn Chaikummao, Sarah Braunstein, W. Utaivoravit, Janneke van de Wijgert, Taweesap Siraprapasiri, and Lauri Markowitz